Alternative Therapies for ALS: Symptom Management & Quality of Life

Complementary Approaches in Amyotrophic Lateral Sclerosis

ALS (Lou Gehrig’s disease) has no cure. Alternative therapies do not alter disease progression but may improve symptom burden and quality of life when integrated with multidisciplinary care.

Nutritional Strategies

• High‑calorie, high‑fat (ketogenic/MAD): May preserve weight, provide alternative neuronal fuel. Small studies show modest functional benefit.
• Mediterranean diet: Anti‑inflammatory, antioxidant; observational link to slower progression.
• Micronutrient optimization: Vitamin D, B12, antioxidants (monitor levels).

Physical & Functional Therapies

• Physical therapy: Range‑of‑motion, stretching, gait training, assistive devices.
• Hydrotherapy: Buoyancy reduces load; maintains mobility.
• Respiratory therapy: NIV (BiPAP), cough assist, breath stacking – extends survival.

Communication Support

• Speech therapy: Voice banking, message banking early.
• AAC devices: Eye‑gaze, head‑tracking, switch scanning – implement before speech loss.

Mind‑Body & Psychosocial

• Mindfulness‑based stress reduction (MBSR): Anxiety, depression, acceptance.
• Cognitive behavioral therapy (CBT): Coping skills.
• Support groups (ALS Association, MDA): Peer connection, resource sharing.
• Palliative care integration early: Symptom management, advance care planning.

Supplements with Some Preclinical Rationale

• Curcumin (turmeric): Anti‑inflammatory, antioxidant; poor bioavailability – use enhanced forms.
• Ginkgo biloba: Antioxidant, microcirculation; interacts with anticoagulants.
• CoQ10, Creatine, L‑carnitine: Mitochondrial support; mixed clinical results.
• Edaravone (Radicava): FDA‑approved antioxidant (IV/oral) – modest functional slowing.

Critical Caveats

• ALWAYS discuss with ALS neurologist & multidisciplinary team.
• Avoid unproven “stem cell clinics,” chelation, hyperbaric oxygen (no ALS evidence).
• Supplements can interact with riluzole, edaravone, anticoagulants.
• Focus on evidence‑based supportive care first.